Amalia Di Giannuario

Amalia Di Giannuario

Auto-generated profile, based on publicly available information

Amalia Di Giannuario

Laboratorio di Farmacologia, Istituto Superiore di Sanità, Rome, Italy

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 September 1999 in Neuroscience Letters
Verified
Journal Article
Closed access
AGAmalia Di Giannuario
Amalia Di Giannuario
SPStefano Pieretti
Stefano Pieretti
ACAnna Catalani
Anna Catalani
ALA Loizzo
A Loizzo

1 March 2001 in Neuropsychobiology
Verified
Journal Article
Closed access
PDF file
AGAmalia Di Giannuario
Amalia Di Giannuario
SPStefano Pieretti
Stefano Pieretti
SSS. Sagratella
S. Sagratella
ALA. Loizzo
A. Loizzo
Previous data indicate that intracerebroventricular administration of agonists for µ- and δ-opioid receptors induces limbic seizures in rats, but no data are reported in rabbits. We found that the µ- and δ-opioid peptides [D-Ala2-N,Me-Phe4-Gly5-ol]enkephalin (DAMGO), β-endorphin and deltorphin II, induced EEG non-convulsive hippocampal seizures, and changes in hippocampal background EEG, physical parameters and overt behaviour after central administration. Dexamethasone pre-treatment prevented DAMGO-, deltorphin II- and β-endorphin-induced seizures as well as changes in background EEG, physical parameters and overt behaviour induced by µ-opioid agonists. Dexamethasone antagonism on opioid action was blocked by pre-treatment with a protein synthesis inhibitor, cycloheximide or by the ĸ-opioid antagonist nor-binaltorphimine. Our data suggest that dexamethasone influences opioid actions at µ- and δ-receptors via a protein synthesis mechanism involving ĸ-opioid receptors.